Eledon Pharmaceuticals, Inc. (ELDN) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 17 transactions totaling $149.1K, demonstrating a bullish sentiment with $149.1K in net insider flow. The most recent transaction on Jan 10, 2026 involved a transaction of 3,430 shares valued at $0.
No significant insider buying has been recorded for ELDN in the recent period.
No significant insider selling has been recorded for ELDN in the recent period.
Based on recent SEC filings, insider sentiment for ELDN is bullish with an Insider Alignment Score of 100/100 and a net flow of $149.1K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Eledon Pharmaceuticals, Inc. (ELDN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading ELDN stock, having executed 17 transactions in the past 90 days. The most active insider is Paul Sean Little (Executive), who has made 1 transactions totaling $88.7K.
Get notified when executives and directors at ELDN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 10, 2026 | Kirk Allan | Executive | Option Exercise | 3,430 | $N/A | $0 | |
| Jan 10, 2026 | Kirk Allan | Executive | Option Exercise | 3,430 | $N/A | $0 | |
| Jan 10, 2026 | Hillson Jan | Executive | Option Exercise | 3,430 | $N/A | $0 | |
| Jan 10, 2026 | Hillson Jan | Executive | Option Exercise | 3,430 | $N/A | $0 | |
| Jan 10, 2026 | S. Mcbride John | Executive | Option Exercise | 3,430 | $N/A | $0 | |
| Jan 10, 2026 | S. Mcbride John | Executive | Option Exercise | 3,430 | $N/A | $0 | |
| May 9, 2024 | Bvf Inc/il | Executive | Purchase | 75,431 | $N/A | $0 | |
| May 9, 2024 | Bvf Inc/il | Executive | Purchase | 821,121 | $N/A | $0 | |
| May 9, 2024 | Bvf Inc/il | Executive | Purchase | 1,031,385 | $N/A | $0 | |
| May 5, 2023 | Trading Fund Os Lp Biotechnology Value | Executive | Purchase | 1,055,445 | $N/A | $0 | |
| May 5, 2023 | Trading Fund Os Lp Biotechnology Value | Executive | Purchase | 86,341 | $N/A | $0 | |
| May 5, 2023 | Trading Fund Os Lp Biotechnology Value | Executive | Purchase | 837,146 | $N/A | $0 | |
| Nov 23, 2022 | Perrin Steven | Executive | Purchase | 1,000 | $2.60 | $2.6K | |
| Dec 20, 2021 | C. Gros David-alexandre | Executive | Purchase | 2,000 | $4.48 | $9.0K | |
| Aug 17, 2021 | C. Gros David-alexandre | Executive | Purchase | 4,000 | $6.21 | $24.8K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 11 | $149.1K | 100.0% |
Exercise(M) | 6 | $0 | 0.0% |
Insiders at Eledon Pharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 8 insiders making 17 transactions totaling $149.1K in purchases versus $0 in sales, the net buying activity of $149.1K signals strong executive confidence. Paul Sean Little (Executive) leads the buying activity with $88.7K in transactions across all time.